Average Ratings 0 Ratings

Total
ease
features
design
support

No User Reviews. Be the first to provide a review:

Write a Review

Average Ratings 0 Ratings

Total
ease
features
design
support

No User Reviews. Be the first to provide a review:

Write a Review

Description

MedAffairs AI is a cloud-based machine learning tool empowered by artificial intelligence, specifically crafted to optimize the Medical Affairs sector within the pharmaceutical industry. Leveraging an extensive repository of medical affairs information, it delivers quick and precise answers to inquiries, thereby minimizing the time users spend sifting through various drives and folders. This innovative platform facilitates the smooth incorporation of internal materials such as clinical trials, standard operating procedures, and articles, allowing users to easily obtain answers by querying their uploaded documents. Each answer provided is linked to the relevant source document, ensuring straightforward referencing. Furthermore, MedAffairs AI enables searches of both internal and external data, offering thorough insights into medical knowledge, regulatory compliance, engagement with key opinion leaders, as well as the formulation and planning of medical strategies. In this way, the tool not only saves time but also enhances the efficiency of the Medical Affairs team in their decision-making processes.

Description

Osmosis AI serves as an interactive study companion seamlessly integrated into the Osmosis learning platform, aimed at assisting medical and health professional students in grasping, reviewing, and solidifying intricate subjects through a mix of AI-driven explanations and reputable educational resources. It combines Elsevier's vast collection of peer-reviewed medical textbooks and materials with the Osmosis visual learning approach, providing responses that are evidence-based, properly cited, and linked to pertinent videos, diagrams, and study aids. This innovative tool allows students to inquire in real time without disrupting their study routine, offering straightforward explanations in accessible language along with direct citations to the original sources for validation. Unlike many platforms that depend on open web data, Osmosis AI functions within a defined "walled garden" of carefully selected medical content, minimizing the occurrence of inaccuracies and ensuring alignment with the educational standards for teaching and assessment in the medical field. As a result, students can engage in a more focused and reliable learning experience that enhances their understanding of complex topics.

API Access

Has API No 

API Access

Has API No 

Screenshots View All

Screenshots View All

Integrations

No details available.

Integrations

No details available.

Pricing Details

No price information available.
Free Trial No 
Free Version No 

Pricing Details

No price information available.
Free Trial Yes 
Free Version No 

Deployment

Web-Based Yes 
On-Premises No 
iPhone App No 
iPad App No 
Android App No 
Windows No 
Mac No 
Linux No 
Chromebook No 

Deployment

Web-Based Yes 
On-Premises No 
iPhone App No 
iPad App No 
Android App No 
Windows No 
Mac No 
Linux No 
Chromebook No 

Customer Support

Business Hours Yes 
Live Rep (24/7) No 
Online Support Yes 

Customer Support

Business Hours No 
Live Rep (24/7) No 
Online Support Yes 

Types of Training

Training Docs Yes 
Webinars No 
Live Training (Online) Yes 
In Person Yes 

Types of Training

Training Docs Yes 
Webinars No 
Live Training (Online) Yes 
In Person No 

Vendor Details

Company Name

Accreditation Council for Medical Affairs (ACMA)

Founded

2015

Country

United States

Website

medaffairsai.org

Vendor Details

Company Name

Elsevier

Founded

1880

Country

The Netherlands

Website

www.elsevier.com/products/osmosis/osmosis-ai

Product Features

Product Features

Alternatives

AIMedInfo Reviews

AIMedInfo

Accreditation Council for Medical Affairs (ACMA)

Alternatives

ACMA Engage Reviews

ACMA Engage

Accreditation Council for Medical Affairs (ACMA)
LeapSpace Reviews

LeapSpace

Elsevier
ANCORA Reviews

ANCORA

Amedea Pharma